Departamento de Desenvolvimento Experimental e Pré-Clinico (DEDEP), Instituto de Tecnologia em Imunobiológico, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.
Departamento de Bioquímica, Instituto Biomédico, Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Front Immunol. 2024 Oct 17;15:1456634. doi: 10.3389/fimmu.2024.1456634. eCollection 2024.
Lactoferrin (Lf) is an important immunomodulator in infections caused by different agents. During SARS-CoV-2 infection, Lf can hinder or prevent virus access to the intracellular environment. Severe cases of COVID-19 are related to increased production of cytokines, accompanied by a weak type 1 interferon response.
We investigated the influence of bovine Lf (bLf) in the immune response during SARS-CoV-2 infection and assays.
Our results show a strong binding between bLf and TLR4/NF-κB , as well as an increase in mRNA expression of these genes in peripheral blood mononuclear cells (PBMCs) treated with bLf. Furthermore, the treatment increased mRNA expression in infected K18-hACE2 mouse blood, indicating an activation of innate response. Our results show that, when bLf was added, a reduction in the NK cell population was found, presenting a similar effect on PD-1 in TCD4 and TCD8 cells. In the culture supernatant of PBMCs from healthy participants, bLf decreased IL-6 levels and increased CCL5 in COVID-19 participants. In addition, K18-hACE2 mice infected and treated with bLf presented an increase of serum pro-inflammatory markers (GM-CSF/IL-1β/IL-2) and upregulated mRNA expression of and in the lung tissue. Furthermore, bLf treatment was able to restore levels in brain tissue.
The data indicate that bLf can be part of a therapeutic strategy to promote the immunomodulation effect, leading to homeostasis during COVID-19.
乳铁蛋白(Lf)是由不同病原体引起的感染中的一种重要免疫调节剂。在 SARS-CoV-2 感染期间,Lf 可以阻止或防止病毒进入细胞内环境。COVID-19 的严重病例与细胞因子的大量产生有关,同时伴有较弱的 1 型干扰素反应。
我们研究了牛乳铁蛋白(bLf)在 SARS-CoV-2 感染期间对免疫反应的影响,并进行了相关实验。
我们的结果显示,bLf 与 TLR4/NF-κB 之间存在强烈的结合,并且 bLf 处理外周血单核细胞(PBMCs)后这些基因的 mRNA 表达增加。此外,该处理增加了感染 K18-hACE2 小鼠血液中的 mRNA 表达,表明先天反应被激活。我们的结果表明,当添加 bLf 时,NK 细胞群减少,TCD4 和 TCD8 细胞中的 PD-1 也表现出类似的效应。在健康参与者的 PBMC 培养上清液中,bLf 降低了 IL-6 水平,增加了 COVID-19 参与者中的 CCL5。此外,感染并接受 bLf 治疗的 K18-hACE2 小鼠表现出血清促炎标志物(GM-CSF/IL-1β/IL-2)水平升高,肺组织中 和 基因的 mRNA 表达上调。此外,bLf 治疗能够恢复脑组织中的 水平。
数据表明,bLf 可以作为一种治疗策略的一部分,以促进免疫调节作用,从而在 COVID-19 期间维持体内平衡。